Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U6 small nuclear RNA 370, pseudogene (RNU6-370P) is a processed, non-functional genomic DNA sequence derived from the U6 small nuclear RNA (snRNA) gene. U6 snRNA is a highly conserved RNA component of the spliceosome, the cellular machinery responsible for removing introns from precursor mRNA in eukaryotes, but the RNU6-370P locus itself does not encode a functional RNA and does not participate in splicing or other biological processes. Pseudogenes like RNU6-370P do not produce proteins or functional RNA; they arise by retrotransposition or duplication followed by inactivation via mutation. There is no evidence RNU6-370P acts as a drug target or biomarker, nor is it implicated in disease.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 370, pseudogene (RNU6-370P).